Clinres farmacija was established in 2000 when Dunja Vujić Podlipec, MPharm PhD opened the first office in Ljubljana, Slovenia.

With over 30 years of experience in clinical and fundamental research in the pharmaceutical industry, she has provided strong and reliable leadership as well as expert guidance in clinical research and regulatory affairs.

Clinres farmacija’s widely sought-after services were followed by inevitable growth in a number of clinical trials in the region of Southeastern Europe. In order to fully address all client requirements, the Clinical Research Department was moved in 2004 to new offices in Zagreb, Croatia by the active Director of Clinical Research, Romana Kajfež PhD – the founder’s daughter. Today, Romana Kajfež acts as the CEO in Zagreb and, with a background in the pharmaceutical industry spanning both science and marketing, provides strong leadership and valuable expertise for the growth of the company.

Under CEO Romana Kajfež’s leadership, sustained growth has led to regional expansion, with the first branch office opening in Belgrade, Serbia in 2007, followed by representative offices in Sarajevo, Bosnia and Herzegovina, and Skopje, North Macedonia in 2008.

Romana’s sister, Tanja Kajfež, PhD acts as the Regulatory and Scientific Affairs Manager (DRA and PV) and successfully manages regulatory affairs and business development of the company.

Collectively, the Kajfež family has already made a substantial contribution to pharmaceutical activities in the region, with Franjo Kajfež – Romana and Tanja’s father – being the author of numerous patents for the rationalization of benzodiazepine synthesis.

ProPharma Group acquired Clinres farmacija companies in November 2023.*

*Clinres farmacija Slovenia was not a part of the acquisition, they are independent entity.